| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kairos Pharma, LTD. | Chief Financial Officer | COMMON STOCK | 293K | $322K | $1.10 | 08 Oct 2025 | Direct |
| GENELUX Corp | Vice President, Finance | Common Stock | 2.3K | $32.6K | $14.18 | 18 Aug 2023 | Direct |
| GENELUX Corp | Vice President, Finance | Stock Option (right to buy) | 40K | 11 Sep 2023 | Direct | ||
| Sacks Parente Golf, Inc. | Chief Financial Officer | Options to Purchase Common Stock | 36K | 09 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | 08 Oct 2025 | 1 | $0 | 4 | Chief Financial Officer | 26 Nov 2025, 17:24 |
| KAPA | Kairos Pharma, LTD. | 22 Nov 2024 | 1 | $3.75K | 4 | Chief Financial Officer | 25 Nov 2024, 06:03 |
| KAPA | Kairos Pharma, LTD. | 16 Sep 2024 | 0 | $0 | 3 | Chief Financial Officer | 24 Sep 2024, 21:00 |
| SPGC | Sacks Parente Golf, Inc. | 09 Sep 2024 | 1 | $0 | 4 | Chief Financial Officer | 12 Sep 2024, 17:56 |
| SPGC | Sacks Parente Golf, Inc. | 09 Sep 2024 | 0 | $0 | 3 | Chief Financial Officer | 12 Sep 2024, 17:52 |
| GNLX | GENELUX Corp | 11 Sep 2023 | 1 | $0 | 4 | Vice President, Finance | 12 Sep 2023, 17:25 |
| GNLX | GENELUX Corp | 18 Aug 2023 | 1 | -$30.8K | 4 | Chief Financial Officer | 22 Aug 2023, 17:17 |
| GNLX | GENELUX CORP | 17 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 02 May 2023, 16:23 |
| GNLX | GENELUX CORP | 25 Jan 2023 | 0 | $0 | 3 | Chief Financial Officer | 25 Jan 2023, 18:26 |